Urothelial Carcinoma
📧 Sign up to get email alerts when something new happens for Urothelial Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-08-17Clinical Trial Update: Study of Cabozantinib Alone or in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid Tumors [Phase 1]
Phase 1 clinical trial update on cabozantinib alone or with atezolizumab for locally advanced or metastatic solid tumors; the study lists mu…
-
CLINICAL_TRIALS research · 2025-08-14Clinical Trial Update: Clinical Trial of AM80 in Combination With Gemcitabine, Cisplatin, and Nivolumab in Patients With Urothelial Carcinoma [Phase 2]
A Phase 2 clinical trial is evaluating AM80 in combination with gemcitabine, cisplatin, and nivolumab for urothelial carcinoma; recruitment …
-
CLINICAL_TRIALS research · 2025-07-29Clinical Trial Update: Research of Double-positive Circulating Cells (Tumor Marker / CD45+) in Several Types of Metastatic Cancers [NA]
A multi-cancer prospective study evaluating double-positive circulating cells (CD45+ tumor marker) in several types of metastatic cancers; r…
-
CLINICAL_TRIALS research · 2025-07-20Clinical Trial Update: Gemcitabine and Carboplatin After Progression on Enfortumab Vedotin and Pembrolizumab in Advanced/Metastatic Urothelial Carcinoma [Phase 2]
A Phase 2 trial evaluating gemcitabine and carboplatin after progression on enfortumab vedotin and pembrolizumab in advanced/metastatic urot…
-
CLINICAL_TRIALS research · 2025-07-18Clinical Trial Update: Neurological Function in Patients With Locally Advanced or Metastatic Urothelial Carcinoma Treated With Enfortumab Vedotin-Based Therapy
A clinical trial update describes neurological function in patients with locally advanced or metastatic urothelial carcinoma treated with en…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-07-17Clinical Trial Update: A Phase III Study of SHR-A2102 Versus Investigator-selected Therapy in Advanced Urothelial Carcinoma [Phase 3]
This clinical trial update indicates a Phase III study (SHR-A2102 vs investigator-selected therapy) for advanced urothelial carcinoma is cur…
-
CLINICAL_TRIALS research · 2025-07-16Clinical Trial Update: A Biomarker Study to Predict Treatment Outcomes of Enfortumab Vedotin in Advanced Urothelial Carcinoma
A biomarker study to predict treatment outcomes of enfortumab vedotin in advanced urothelial carcinoma; the trial is currently active but no…
-
CLINICAL_TRIALS research · 2025-06-17Clinical Trial Update: The Exploration of Novel Radionuclide-labeled HER2-targeting Antibodies in the Diagnosis of HER2-positive Malignancies [EARLY_Phase 1]
An early-phase 1 trial evaluating a radionuclide-labeled HER2-targeting antibody for diagnostic use in HER2-positive cancers, with enrollmen…
-
CLINICAL_TRIALS research · 2025-06-17Clinical Trial Update: PET Image Exploration of 89Zr-labeled Antibody Fragments Targeting HER2 in Patients With Malignant Tumors [EARLY_Phase 1]
Early-phase PET imaging study evaluating 89Zr-labeled antibody fragments targeting HER2 in patients with malignant tumors to assess uptake a…
-
CLINICAL_TRIALS research · 2025-06-05Clinical Trial Update: Study Comparing the Standard Administration of IO Versus the Same IO Administered Each 3 Months in Patients in Response After 6 Months of Standard IO [Phase 3]
A Phase 3 trial is evaluating whether an immune-oncology therapy given every three months after six months of standard administration is as …
-
CLINICAL_TRIALS research · 2025-06-05Clinical Trial Update: Observational Study of Muscle Invasive Urothelial Carcinoma Participants Treated With Adjuvant Nivolumab in France
An observational study of muscle-invasive urothelial carcinoma patients treated with adjuvant nivolumab in France has been terminated.
-
CLINICAL_TRIALS research · 2025-05-29Clinical Trial Update: Clinical Application of PET Imaging Targeting Nectin-4 in Malignant Tumors [NA]
A clinical trial update describes PET imaging targeting Nectin-4 in malignant tumors and lists urothelial carcinoma, breast cancer, and lung…
-
CLINICAL_TRIALS research · 2025-05-22Clinical Trial Update: Diagnostic Efficacy and Dosimetry of MNPR-101-DFO*-89Zr in Patients With Solid Tumors [Phase 1]
This ClinicalTrials.gov update describes a Phase 1 study evaluating MNPR-101-DFO*-89Zr as a diagnostic imaging agent for adults with various…
-
CLINICAL_TRIALS research · 2025-05-21Clinical Trial Update: A Patient-Directed Mobile Tool to Streamline the QoL Assessment and Monitoring in Urothelial Carcinoma
This clinical trial entry describes a patient-directed mobile tool to streamline quality-of-life assessment and monitoring in urothelial car…
-
CLINICAL_TRIALS research · 2025-05-20Clinical Trial Update: Phase I-II, FIH, TROP2 ADC, Advanced Unresectable/Metastatic Solid Tumors, Refractory to Standard Therapies (KL264-01) [Phase 1, Phase 2]
KL264-01, a Trop2-targeted antibody-drug conjugate, is being studied in a Phase 1/2 trial for advanced unresectable or metastatic solid tumo…
-
CLINICAL_TRIALS research · 2025-05-07Clinical Trial Update: A Study of BL-B01D1 + PD-1 in Patients With Locally Advanced or Metastatic Urothelial Carcinoma [Phase 2]
Phase 2 study evaluating BL-B01D1 in combination with a PD-1 inhibitor for locally advanced or metastatic urothelial carcinoma is currently …
-
CLINICAL_TRIALS research · 2025-04-13Clinical Trial Update: A Study to Evaluate 9MW2821 Versus Chemotherapy in Subjects With Previously Treated Locally Advanced or Metastatic Urothelial Cancer [Phase 3]
A Phase 3 clinical trial is evaluating 9MW2821 versus chemotherapy in patients with previously treated locally advanced or metastatic urothe…
-
CLINICAL_TRIALS research · 2025-04-13Clinical Trial Update: Bladder Cancer Screening Trial [NA]
A bladder cancer screening trial sponsored by the University of Texas Southwestern Medical Center is currently recruiting, investigating bla…
-
CLINICAL_TRIALS research · 2025-04-08Clinical Trial Update: Performance Evaluation of a Urine-based Methylation Assay for Urothelial Carcinoma
This clinical trial update describes the performance evaluation of a urine-based methylation assay for urothelial carcinoma. The study statu…
-
CLINICAL_TRIALS research · 2025-04-03Clinical Trial Update: Modular Trial of sEphB4-HSA in EphrinB2-High Solid Tumors [Phase 2, Phase 3]
This clinical trial update notes a modular Phase 2/Phase 3 study of sEphB4-HSA in EphrinB2-high solid tumors, with recruitment ongoing for m…
-
CLINICAL_TRIALS research · 2025-04-02Clinical Trial Update: ARON-2 Study-Multicentric International Retrospective Study
ARON-2 is a multicenter international retrospective study focusing on urothelial carcinoma, currently recruiting sites/investigators to part…
-
CLINICAL_TRIALS research · 2025-04-01Clinical Trial Update: Probiotics in Advanced Urothelial Carcinoma [Phase 2]
A Phase 2 clinical trial at Sun Yat-sen University is evaluating probiotics in patients with advanced urothelial carcinoma; the study is cur…
-
CLINICAL_TRIALS research · 2025-03-26Clinical Trial Update: Adjuvant Sacituzumab Govitecan and Nivolumab in Muscle-Invasive Urothelial Carcinoma At High-Risk Recurrence [Phase 2]
Phase 2 trial evaluating adjuvant sacituzumab govitecan in combination with nivolumab for high-risk, resected muscle-invasive urothelial car…
-
CLINICAL_TRIALS research · 2025-03-21Clinical Trial Update: 9MW2821 + Toripalimab vs 9MW2821 for 1st Line Locally Advanced or Metastatic Urothelial Carcinoma [Phase 2]
Phase 2 trial evaluating 9MW2821 plus toripalimab versus 9MW2821 alone as first-line treatment for locally advanced or metastatic urothelial…
-
CLINICAL_TRIALS research · 2025-03-12Clinical Trial Update: A Multicenter Cancer Biospecimen Collection Study
A multicenter cancer biospecimen collection trial sponsored by Cofactor Genomics is currently recruiting, covering multiple cancer indicatio…